Head-to-head comparison
RestorLife Med vs Signos
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
RestorLife Med is a physician-guided GLP-1 telehealth practice (founder Dr.
$199/mo (6-month prepay) sema · Verified August 2026
Marked down on: The advertised $299 is a struck-through anchor price, not a starting point: the real month-to-month rate is $299, a first month runs $149 at 50% off, and the $199 rate needs six months
Desk Score
Signos (Signos+) is a metabolic-health platform that bundles clinician-prescribed compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor (CGM) and app.
$199/mo (6-month prepay) sema · From $199/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: Compounded GLP-1s are not FDA-approved finished products
RestorLife Med takes this head-to-head with the higher Desk Score, 80/100 (B−) against 62/100 (C) for Signos. Signos still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
RestorLife Med
80/100
B−
Signos
62/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | RestorLife Med | Signos |
|---|---|---|
| Semaglutide | $199/mo6-month prepay$199/mo (6-month plan, compounded) | $199/mo6-month prepay$199/mo (6-month plan, compounded) |
| Tirzepatide | Not listed on RestorLife Med's site (checked August 2026) | From $199/molowest dose rung$199/mo (starting dose, compounded) |
| Coverage | All 50 states | Not listed on Signos's site (checked July 2026) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | GLP-1 weight care from a named board-certified physician, with microdosing and strong clinical support. | Pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app. |
| Desk Score | 80/100B− | 62/100C |
The verdict
Desk pick — RestorLife MedRestorLife Med takes this head-to-head with the higher Desk Score, 80/100 (B−) against 62/100 (C) for Signos. Signos still holds its ground where its strengths line up with yours.
Choose RestorLife Med if…
GLP-1 weight care from a named board-certified physician, with microdosing and strong clinical support.
$199/mo (6-month prepay) sema · All 50 states
Choose Signos if…
Pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app.
$199/mo (6-month prepay) sema · From $199/mo (lowest dose rung) tirz
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: RestorLife Med · Signos.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs RestorLife Med
- CoreAge Rx vs Signos
- RestorLife Med vs Vaylen
- HealthRX vs Signos
- HealthRX vs RestorLife Med
- Renlo Health vs Signos
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.